A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and children

Shigella sonnei live vaccine candidate, WRSS1, which was previously evaluated in US, Israeli and Thai volunteers, was administered orally to Bangladeshi adults and children to assess its safety, clinical tolerability and immunogenicity. In a randomized, placebo-controlled, dose-escalation, age-desce...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Hum Vaccin Immunother
Main Authors: Raqib, Rubhana, Sarker, Protim, Zaman, K., Alam, Nur Haque, Wierzba, Thomas F., Maier, Nicole, Talukder, Kaisar, Baqui, Abdullah Hel, Suvarnapunya, Akamol E., Qadri, Firdausi, Walker, Richard I., Fix, Alan, Venkatesan, Malabi M.
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2019
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6663145/
https://ncbi.nlm.nih.gov/pubmed/30794051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1575165
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares